Europeans and biotechnologies in 2010 - Winds of change?
By Nanowerk News,
Nanowerk News
| 11. 15. 2010
The European Commission has released their new report "Europeans and biotechnology in 2010 – Winds of change?" (pdf). This latest Eurobarometer survey on the Life Sciences and Biotechnology, which also specifically addresses nanotechnologies in the context of biotechnology, is based on representative samples from 32 European countries and conducted in February 2010. The report points to a new era in the relations between science and society. While entrenched views about GM food are still evident, the crisis of confidence in technology and regulation that characterised the 1990s – a result of BSE, contaminated blood and other perceived regulatory failures – is no longer the dominant perspective.
In 2010 we see a greater focus on technologies themselves: are they safe? Are they useful? And are there 'technolite'alternatives with more acceptable ethical-moral implications? Europeans are also increasingly concerned about energy and sustainability. There is no rejection of the impetus towards innovation: Europeans are in favour of appropriate regulation to balance the market, and wish to be involved in decisions about new technologies when social values are at stake.
Here is an overview...
Related Articles
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
By Maia Hibbett, Wired | 09.09.2026
THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conservatory-trained viola player from Chongqing, China, a lover of science fiction, and an aspiring member of the US Army Reserve Officer Training...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Claire Robinson and Jonathan Matthews, Guest Contributors
| 08.25.2026
This is an excerpt of an article originally published on August 1, 2026 at GMWatch.
A six-year-old girl has died in a gene editing gene therapy trial in China that went wrong, the journal Science reports. Seven days after the girl's medical team infused trillions of viruses carrying the recipe for the gene editing tool – in this case a base editor – into her spinal fluid, she died of a severe immune reaction linked to the therapy.
Just...